Innovative Neurovascular Access System Gains CE Mark Approval
Q'Apel Medical Secures CE Mark for Groundbreaking Access System
Q'Apel Medical has reached a significant milestone by receiving CE mark certification for its pioneering Armadillo SelectFlex™ Neurovascular Access System. This innovative technology transforms how medical professionals access neurovascular areas, enhancing the ability to navigate complex anatomical structures.
Features of the Armadillo SelectFlex™
The Armadillo SelectFlex™ Neurovascular Access System incorporates patented SelectFlex™ technology that equips operators to achieve an exceptional balance of trackability and support. This capability is particularly crucial for navigating intricate neurovasculature, ensuring both flexibility and stability during procedures.
Versatile Biaxial Approach
Unlike conventional configurations, the Armadillo system enables a biaxial approach, simplifying access regardless of the entry point. This design minimizes the complexity often associated with traditional tri-axial systems while also reducing costs, making it a practical choice for healthcare providers.
Expert Insights on the New Technology
Commenting on the new system, Dr. Pascal Jabbour, a prominent neurological surgeon, emphasized the difficulties posed by neurovascular access. He noted, "Neurovascular access can be extremely challenging. The tortuous anatomy requires flexibility to navigate the tight twists and turns. However, flexible access catheters tend to lack the support and stability required for device delivery once positioned."
The Advantage of Control
Dr. Jabbour further elaborated on how the Armadillo system simplifies these procedures: "Armadillo provides a one-and-done solution that simplifies access procedures. It is designed to place full control in the hands of the operator, allowing for easy transformation of the catheter’s functionality with just a small injection of saline. This innovative approach greatly enhances the experience for medical personnel and improves patient outcomes."
Q'Apel Medical's Vision and Future
According to Jodie Fam, the CEO of Q'Apel Medical, this latest advancement addresses existing gaps in neurovascular access technologies. She stated, "The Armadillo Neurovascular Access System with SelectFlex™ Technology addresses the shortcomings of currently available neurovascular access catheters. We believe it provides a novel option that allows hospitals to standardize device usage, decrease inventory constraints, and reduce cost per procedure."
Furthermore, Fam expressed gratitude towards her team for their dedication in achieving this milestone: "We look forward to building upon Armadillo's U.S. commercial success as we prepare to expand our international portfolio and deliver this meaningful solution to the European market, and others, in the coming months."
About Q'Apel Medical
Q'Apel Medical is on the path to revolutionizing neurovascular interventions by developing innovative products aligned with the needs of medical professionals. The company focuses on overcoming clinical challenges with cutting-edge engineering designed in collaboration with neurovascular specialists. Their goal is to create high-quality, versatile medical solutions that address current requirements while anticipating future needs.
Contact Information
For further inquiries, please reach out to Charlene Herndon of SPRIG Consulting.
Frequently Asked Questions
What is the Armadillo SelectFlex™ Neurovascular Access System?
This system is an advanced medical device designed to enhance neurovascular access, featuring patented technology for improved maneuverability and support.
How does the SelectFlex™ technology work?
SelectFlex™ technology allows the catheter to switch between highly trackable and highly supportive states with a simple saline injection, enhancing operational control during procedures.
What are the benefits of a biaxial approach?
The biaxial approach simplifies access to neurovascular pathways, reducing complexity and costs compared to traditional tri-axial configurations.
How will this technology impact hospitals?
This innovative solution aims to standardize device usage in hospitals, minimize inventory needs, and reduce the overall cost associated with neurovascular procedures.
What can we expect from Q'Apel Medical in the future?
Q'Apel Medical plans to leverage its success in the U.S. market to further expand its international product offerings, bringing innovative solutions to more healthcare providers globally.
About The Author
Contact Ryan Hughes privately here. Or send an email with ATTN: Ryan Hughes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.